Calls for papers

In this cross-journal Collection, we invite submissions of primary research articles that focus on preclinical and clinical development of immune cell-based therapies for cancer treatment.

This cross-journal Collection between Communications Physics, Nature Communications, and Scientific Reports welcomes contributions where the description of the dynamics of biological droplets advances our understanding of specific biological processes, as well as more general contributions identifying common mechanisms and generating novel biophysical insight across the realm of biological droplets.

This cross-journal Collection between Nature Communications, Communications Biology, npj Genomic Medicine and Scientific Reports brings together research articles that provide new insights into the biology of rare genetic disorders, also known as Mendelian or monogenic disorders.

This cross-journal Collection between Nature Communications, Communications Biology and Scientific Reports welcomes submissions on the molecular biology of RNA modifications and methods developed to identify and characterize them.

Plastics are a crucial part of modern life, however tens of millions of tonnes of plastic waste is disposed of each year, much of which ultimately ends up in the ocean. In this Collection we showcase studies on understanding and mitigating (micro)plastic pollution, with a special focus on reducing plastic waste in the environment to coincide with 2024's upcoming binding UN treaty on Ending Plastic Pollution.

This cross-journal collection welcomes the submission of primary research articles that focus on neuronal circuits in the hypothalamus involved in feeding/metabolism and other motivated behaviors.

This Collection will highlight Articles that involve new tools and emerging techniques for imaging at increased penetration depths within tissue as well as considering advances in conventional and state-of-the-art light microscopy techniques.

In this collection, we want to highlight research that focuses on fragments in drug discovery. Have you found validated fragment hits for a new disease target? Maybe they unlocked an unreported enzyme mechanism? Were you able to develop a method that is useful for fragment-based drug discovery? Perhaps you found a hit that made it to clinical trials? We invite all scientists who work with fragments in the context of drug discovery to submit their interesting fragment stories. We look forward to hearing all about them.

With this collection, Nature Communications, Nature Medicine, Communications Medicine and Scientific Reports aim to publish research articles spanning the breadth of AMR and across microbial pathogens (bacteria, viruses, fungi and parasites). This includes, and is not limited to epidemiological monitoring of resistance incidence in clinical and environmental settings, novel strategies aiming to combat or prevent AMR (i.e. drug repurposing, drug synergy treatment, and vaccines), improvements in diagnostics, and subsequently tailored treatment, of drug-resistant infections.

This collection aims to improve understanding how the immune system changes during aging and welcomes submissions to Nature Communications, Communications Biology, and Scientific Reports.